Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea · Delayed Price · Currency is KRW 1,548,000
-16,000 (-1.02%)
At close: Aug 14, 2026
Samsung Biologics Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 4,814,546 | 4,556,972 | 3,497,146 | 3,694,589 | 3,001,295 | 1,568,007 |
Revenue Growth | 35.63% | 30.30% | -5.34% | 23.10% | 91.41% | 34.62% |
Gross Profit Gross Profit Growth | 2,641,294 | 2,500,841 | 1,699,053 | 1,794,509 | 1,460,769 | 723,350 |
Operating Income Operating Income Growth | 2,219,734 | 2,069,221 | 1,321,366 | 1,113,680 | 983,627 | 537,309 |
Net Income Net Income Growth | 1,878,044 | 1,784,352 | 1,083,316 | 857,691 | 798,056 | 393,589 |
Earnings Per Share EPS Growth | 43103.95 | 40941.49 | 23402.33 | 18528.27 | 17577.11 | 9146.19 |
EPS Growth | 55.95% | 74.95% | 26.31% | 5.41% | 92.18% | 63.33% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Product Product Growth | 4,358,256 | 4,358,256 | 3,380,431 | 3,402,983 | 2,788,707 | 1,441,997 |
Other Other Growth | 198,716 | 198,716 | 116,715 | 291,605 | 212,588 | 126,010 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,652,954 | 1,485,083 | 1,331,289 | 2,056,276 | 3,193,537 | 1,371,435 |
Total Debt Total Debt Growth | 1,194,488 | 927,094 | 1,486,239 | 1,909,333 | 2,514,033 | 1,292,747 |
Net Cash (Debt) Net Cash Growth | 458,466 | 557,989 | -154,951 | 146,943 | 679,504 | 78,688 |
Net Cash Growth | - | - | - | -78.38% | 763.54% | 17.19% |
Net Cash Per Share Net Cash Per Share Growth | 10522.48 | 12802.91 | -3347.32 | 3174.34 | 14965.87 | 1828.54 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 2,332,509 | 2,247,807 | 1,659,255 | 1,666,229 | 953,048 | 454,596 |
Capital Expenditures CapEx Growth | -852,774 | -1,391,741 | -1,303,573 | -995,071 | -956,840 | -406,254 |
Free Cash Flow Free Cash Flow Growth | 1,479,735 | 856,067 | 355,682 | 671,158 | -3,792 | 48,343 |
Free Cash Flow Growth | 628.50% | 140.68% | -47.01% | - | - | -22.56% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 54.86% | 54.88% | 48.58% | 48.57% | 48.67% | 46.13% |
Operating Margin | 46.11% | 45.41% | 37.78% | 30.14% | 32.77% | 34.27% |
Pretax Margin | 48.19% | 46.49% | 39.60% | 30.31% | 33.62% | 35.80% |
Profit Margin | 39.01% | 39.16% | 30.98% | 23.21% | 26.59% | 25.10% |
FCF Margin | 30.73% | 18.79% | 10.17% | 18.17% | -0.13% | 3.08% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 38.89 | 43.97 | 62.35 | 63.07 | 73.22 | 151.80 |
Forward PE | 35.13 | 42.21 | 62.18 | 60.08 | 82.37 | 112.20 |
P/FCF Ratio | 48.93 | 91.66 | 189.90 | 80.60 | - | 1235.91 |
PS Ratio | 15.04 | 17.22 | 19.31 | 14.64 | 19.47 | 38.10 |